Abstract
Congenital heart disease (CHD) is the most common congenital malformation group and is the leading cause of newborn mortality in developed countries. Most of the infants with CHD develop pre-operative or postoperative acute kidney injury (AKI). AKI may develop before the serum creatinine rise and oliguria. Urinary biomarkers such as Kidney Injury Molecule-1 (KIM-1), Neutrophil gelatinase-associated lipocalin (NGAL), Interleukin (IL)-18 and Cystatin C may predict AKI in patients with critical CHD (CCHD) before the serum creatinine rise. In this study, we aimed to determine the AKI incidence among newborns patients with CCHD, also to investigate the predictivity of urinary biomarkers for AKI. Newborns with a gestational age >34 weeks and birth weight >1500 grams with a diagnosis of CCHD were enrolled to the study. Blood and urine samples were collected at birth and during the first 24-48th hour, preoperative and postoperative period. A total of 53 CCHD patients requring surgery during the neonatal period were enrolled in the study. The 24-48th hour KIM-1 levels of the cases with exitus were higher (p=0.007). The 24-48th hour cystatin C and preoperative NGAL levels were higher in patients with postoperative AKI (p=0.02). In newborns with CCHD; high KIM-1 levels may predict mortality whereas high cystatin C and preoperative NGAL levels may be indicative for AKI. These biomarkers deserve investigations in larger study populations.

This publication has 17 references indexed in Scilit: